Study for Women With Platinum Resistant Ovarian Cancer Evaluating EC145 in Combination With Doxil® (PROCEED)

This study has suspended participant recruitment.
(DSMB decision)
Sponsor:
Information provided by (Responsible Party):
Endocyte
ClinicalTrials.gov Identifier:
NCT01170650
First received: July 7, 2010
Last updated: August 3, 2015
Last verified: August 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has suspended participant recruitment.
  Estimated Study Completion Date: October 2016
  Primary Completion Date: May 2015 (Final data collection date for primary outcome measure)